Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mirum Pharmaceuticals (MIRM) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Mirum Pharmaceuticals (MIRM) over the last 6 years, with Q3 2025 value amounting to $93.5 million.

  • Mirum Pharmaceuticals' Short-term Investments rose 5213.58% to $93.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $93.5 million, marking a year-over-year increase of 5213.58%. This contributed to the annual value of $57.8 million for FY2024, which is N/A changed from last year.
  • As of Q3 2025, Mirum Pharmaceuticals' Short-term Investments stood at $93.5 million, which was up 5213.58% from $76.4 million recorded in Q2 2025.
  • In the past 5 years, Mirum Pharmaceuticals' Short-term Investments ranged from a high of $149.6 million in Q3 2022 and a low of $3.0 million during Q3 2023
  • For the 5-year period, Mirum Pharmaceuticals' Short-term Investments averaged around $86.4 million, with its median value being $82.7 million (2023).
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Short-term Investments tumbled by 9801.39% in 2023, and later surged by 196920.23% in 2024.
  • Mirum Pharmaceuticals' Short-term Investments (Quarter) stood at $125.2 million in 2021, then dropped by 1.19% to $123.7 million in 2022, then tumbled by 97.6% to $3.0 million in 2023, then soared by 1845.88% to $57.8 million in 2024, then soared by 61.78% to $93.5 million in 2025.
  • Its Short-term Investments was $93.5 million in Q3 2025, compared to $76.4 million in Q2 2025 and $65.9 million in Q1 2025.